Naloxone-Induced Acute Pulmonary Edema is Dose-Dependent: A Case Series
| Autor: | Mustafa Al-Taei, Mohammed AlAzzawi, Steven Douedi, Eric J. Costanzo, Ghadier Alsaoudi, Abbas Alshami |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Drug-Related Side Effects and Adverse Reactions Narcotic Antagonists Pulmonary Edema 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Naloxone Detoxification Intensive care medicine Humans Dosing Intensive care medicine Adverse effect Heart Failure business.industry Opioid overdose Articles General Medicine Pulmonary edema medicine.disease Analgesics Opioid 030220 oncology & carcinogenesis Heart failure Drug Overdose business medicine.drug |
| Zdroj: | The American Journal of Case Reports |
| ISSN: | 1941-5923 |
| Popis: | Case series Patients: Male, 29-year-old • Male, 37-year-old Final Diagnosis: Noncardiogenic pulmonary edema Symptoms: Dyspnea Medication: — Clinical Procedure: — Specialty: Critical Care Medicine • Pulmonology Objective: Challenging differential diagnosis Background: Naloxone remains the mainstay for the treatment of opioids overdose both in the clinical and public settings. Naloxone has been showing relative safety, leading to trivial adverdse effects which are mostly due to acute withdrawal effects, but when used in patients with known long-term addiction, it usually requires additional dosing or rapid infusion to achieve detoxification effects in a timely manner or to sustain the effects after they fade away. In some patients this has resulted in fatal adverse effects, including non-cardiogenic pulmonary edema (NCPE), which may require intensive care for those patients. Whether the higher dose is the cause has been debatable and not enough studies have looked into this subject. Case Reports: Here, we report a series of 2 cases where 2 young patients were given naloxone following opioid overdose. Both our patients required frequent dosing due to insufficient response or owing to the washout of the naloxone effect shortly after, given its short half-life. Although the administered doses were different, both patients developed the adverse effect of NCPE and required ventilator support. Conclusions: Evidence suggests that such a catastrophic adverse effect following the administration of such a critical medication, which is known to be relatively safe and is being publicized for saving lives, might limit its use and would require more attention and further studies to standardize a safe dose, limiting these life-threatening events and decreasing the need for unnecessary invasive respiratory support as well as admissions to intensive care units, which might create an additional burden on the health care system. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|